Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is a second transurethral resection necessary in T1 bladder cancer?

Nature Clinical Practice Urology volume 4, pages 12–13 (2007)Cite this article

boxed-textSchwaibold HE et al. (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97: 1199–1201

T1 bladder cancer has a high risk of recurrence and progression and should be treated with wide surgical excision, resection of the tumor base and margin, postoperative chemotherapy, and repeat resection if initial surgery was inadequate

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Zurkirchen MA et al. (2004) Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int 72: 99–102

    Article  CAS  Google Scholar 

  2. Sylvester RJ et al. (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186–2190

    Article  Google Scholar 

  3. Lamm DL : BCG immunotherapy: effective management of superficial bladder cancer. Contemp Urol, in press

  4. Hassan JM et al. (2004) Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 172: 882–884

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Donald Lamm, University of Arizona and BCG Oncology, and Tamsin Osborne, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. BCG Oncology, Suite E, 16620 North 40th Street, Phoenix, AZ 85032, USA bcgoncology@cox.net

Authors and Affiliations

  1. D Lamm is a Clinical Professor at the University of Arizona, Tucson, and the Director of BCG Oncology, Phoenix, AZ, USA.,

    Donald Lamm

Authors
  1. Donald Lamm
    View author publications

    Search author on:PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lamm, D. Is a second transurethral resection necessary in T1 bladder cancer?. Nat Rev Urol 4, 12–13 (2007). https://doi.org/10.1038/ncpuro0659

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpuro0659

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing